CC Pollen Company
FDA issued a warning letter to CC Pollen Company (Glendale, AZ) following an April 2025 inspection of its dietary supplement manufacturing facility. The agency found multiple serious CGMP violations related to its Bee Pollen Granules and Royal Jelly capsules, including failure to establish finished product specifications, failure to reject out-of-spec components, missing master manufacturing records, and inadequate identity testing of dietary ingredients. The products were also deemed misbranded due to an incorrect serving size declaration on the Royal Jelly capsules label. FDA demanded written corrective action within 15 working days and warned that failure to comply may result in seizure or injunction.
Flagged claims (1)
1-2 capsules once daily
Required actions (2)
Please notify FDA in writing, within 15 working days of receipt of this letter, of the specific steps you have taken to address any violations. Include an explanation of each step being taken to prevent the recurrence of violations, as well as copies of related documentation.
Failure to adequately address this matter may result in legal action including, without limitation, seizure and injunction.
Does your site contain similar claims?
The free site audit scans your whole site against every entry in this Atlas. Most nutrition / supplements sites match 3-6 patterns.
Run my free site auditWorried about one specific page, ad, or email? Paste it into the free Claim Checker and see what the FDA and FTC would flag, with the precedent next to each one. No email required.
Check specific copy in the Claim Checker